Fré Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Fré Pharma
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Debts after one year -€103,251
down €103,251 (-32.4%), from €318,243 to €214,992
- Other debts +€49,050
up €49,050 (+16.3%), from €300,535 to €349,585
- Reserves +€40,000
up €40,000 (+8.9%), from €447,500 to €487,500
- Tax, wage and social debts +€21,438
up €21,438 (+199.7%), from €10,733 to €32,171
- Gross operating margin +€9,816
up €9,816 (+14.3%), from €68,455 to €78,271
- Taxes +€6,456
up €6,456 (+43.0%), from €15,004 to €21,460
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,245,453 | €1,260,727 | +€15,274 | +1.2% |
| Fixed assets | 21/28 | €1,223,080 | €1,225,702 | +€2,622 | +0.2% |
| Tangible fixed assets | 22/27 | €4,726 | €7,349 | +€2,622 | +55.5% |
| Land and buildings | 22 | €4,726 | €4,726 | = | 0.0% |
| Furniture and vehicles | 24 | - | €2,622 | +€2,622 | |
| Financial fixed assets | 28 | €1,218,353 | €1,218,353 | = | 0.0% |
| Current assets | 29/58 | €22,373 | €35,025 | +€12,652 | +56.5% |
| Amounts receivable within one year | 40/41 | €10,921 | €18,731 | +€7,810 | +71.5% |
| Trade receivables | 40 | €10,920 | €1,231 | -€9,689 | -88.7% |
| Other amounts receivable | 41 | €1 | €17,500 | +€17,499 | +1388788.9% |
| Cash at bank and in hand | 54/58 | €9,828 | €14,608 | +€4,780 | +48.6% |
| Deferred charges and accrued income | 490/1 | €1,624 | €1,686 | +€62 | +3.8% |
| Total equity and liabilities | 10/49 | €1,245,453 | €1,260,727 | +€15,274 | +1.2% |
| Equity | 10/15 | €506,320 | €546,583 | +€40,263 | +8.0% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €447,500 | €487,500 | +€40,000 | +8.9% |
| Distributable reserves | 133 | €447,500 | €487,500 | +€40,000 | +8.9% |
| Profit (loss) carried forward | 14 | €8,820 | €9,083 | +€263 | +3.0% |
| Amounts payable | 17/49 | €739,133 | €714,144 | -€24,989 | -3.4% |
| Amounts payable after more than one year | 17 | €318,243 | €214,992 | -€103,251 | -32.4% |
| Financial debts | 170/4 | €318,243 | €214,992 | -€103,251 | -32.4% |
| Amounts payable within one year | 42/48 | €417,032 | €495,964 | +€78,931 | +18.9% |
| Current portion of amounts payable after more than one year | 42 | €99,869 | €103,251 | +€3,381 | +3.4% |
| Trade debts | 44 | €5,895 | €10,958 | +€5,063 | +85.9% |
| Suppliers | 440/4 | €5,895 | €10,958 | +€5,063 | +85.9% |
| Taxes, remuneration and social security | 45 | €10,733 | €32,171 | +€21,438 | +199.7% |
| Taxes | 450/3 | €10,733 | €32,171 | +€21,438 | +199.7% |
| Other amounts payable | 47/48 | €300,535 | €349,585 | +€49,050 | +16.3% |
| Accrued charges and deferred income | 492/3 | €3,858 | €3,188 | -€670 | -17.4% |
| Non-recurring operating income | 76A | €7,823 | - | -€7,823 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €644 | +€644 | |
| Other operating charges | 640/8 | €1,933 | €2,566 | +€633 | +32.7% |
| Gross operating margin | 9900 | €68,455 | €78,271 | +€9,816 | +14.3% |
| Operating profit (loss) | 9901 | €66,522 | €75,060 | +€8,539 | +12.8% |
| Financial charges | 65/66B | €13,403 | €13,337 | -€67 | -0.5% |
| Recurring financial charges | 65 | €13,403 | €13,337 | -€67 | -0.5% |
| Profit (loss) for the period before taxes | 9903 | €53,118 | €61,724 | +€8,605 | +16.2% |
| Income taxes | 67/77 | €15,004 | €21,460 | +€6,456 | +43.0% |
| Profit (loss) for the period | 9904 | €38,114 | €40,263 | +€2,149 | +5.6% |
| Profit (loss) for the period to be appropriated | 9905 | €38,114 | €40,263 | +€2,149 | +5.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.